600 Patients Recruited in Active Biotech's and Ipsen's tasquinimod Clinical ... 
Reuters
The partnership with Ipsen has significantly increased the potential of this novel approach to treat cancer." About tasquinimod Tasquinimod has a pleiotropic mode of action which includes immunomodulatory, anti-angiogenic and anti-metastatic activity.
Ipsen, Active Biotech Say 600 Patients Recruited In Phase 3 Tasquinimod Study NASDAQ
Ipsen/Active Biotech Phase III prostate cancer study progressing well Pharma Times
Active Biotech gets ?10m milestone payment Stock Market Wire

all 20 news articles » 

New developments in metastatic breast cancer to be reported at ASCO 2012 ... 
The Imperfect Parent
Biotechnology pioneer company Genentech is moving ahead with its latest advance in the treatment of metastatic breast cancer. Data from its newest therapy, TDM-1, will be showcased at the premier annual cancer meeting in America called ASCO (American ...
Sanofi details ASCO cancer pipeline presentation plans Zenopa

all 4 news articles » 

New Drug for Advanced Melanoma: Potential Breakthrough 
Ivanhoe
A phase 1 trial shows the new drug causes substantial shrinking of metastatic tumours in patients. Dabrafenib blocks the activity of the cancer-causing mutated form of the BRAF gene, which is seen in about half of melanomas. BRAF is a known oncogene, ...
Texas Sized Results for Melanoma Drug Trial dailyRx
New hope for drug to prolong melanoma survival The Australian
Drug shrinks brain tumours ScienceAlert
French Tribune  -Ninemsn 
all 9 news articles » 

Al-Megrahi, convicted in 1988 Lockerbie bombing, dies of cancer 
Denver Post
... American jetliner over Lockerbie, Scotland, has died in Libya, family members told news agencies Sunday, nearly three years after Scotland released him on humanitarian grounds, citing evidence that he was near death with metastatic prostate cancer.
Lockerbie Bomber Dies In Libya Newsroom America

all 3,295 news articles » 

Mesothelioma and Lung Cancer Patients To Get Boost From Research by ?Young ... 
MesotheliomaHelp.net (blog)
The research will benefit mesothelioma patients and lung cancer patients as the scientists search for treatments focused on killing cancer cells and preventing metastasis of the aggressive diseases. Pleural mesothelioma is a form of lung cancer that is ...

and more » 

Letters: 
The Oshkosh Northwestern
Secondary or metastatic brain tumors begin as cancer in another part of the body. Cancer cells spread to the brain by the blood. Children and older adults have a higher incidence of primary brain tumors. Some brain tumors are cancerous and some are not ...

and more » 

Study: APRNs bring palliative care to oncology units 
Nurse.com
A consultative visit between a nurse practitioner and a metastatic cancer patient goes a long way toward improving the patient's emotional and mental well-being, according to researchers with the Mayo Clinic. The researchers said the results were ...

and more » 

Stopping cell migration may help block fibrosis and the spread of cancer 
HealthCanal.com
By Helen Dodson - Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling pathway that promotes cell migration in ...

and more » 

Dabrafenib Safe in Melanoma With Brain Mets 
MedPage Today
... in 69% (95% CI 51.9 to 83.7) and confirmed responses in 50% (95% CI 32.9 to 67.1) of 36 patients with the most common form of BRAF-mutated metastatic melanoma, reported Gerald Falchook, MD, from MD Anderson Cancer Center in Houston, and colleagues.
ASCO: Dabrafenib/Trametinib active in metastatic melanoma Medical Xpress
Drug could boost brain cancer survival The Australian
Two-Drug Combo May Be Safe for Melanoma Treatment Health.com
TopNews New Zealand 
all 51 news articles » 

Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data ... 
SunHerald.com
The presentation will provide overall survival (OS) data from the tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC). The poster ?Tasquinimod and survival in men with metastatic castration-resistant ...

and more »